---
title: "EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292896946.md"
description: "EyePoint, Inc., a company based in Watertown, Mass., disclosed on July 16, 2026, that it has issued non-statutory stock options to new employees as part of their inducement awards. These options were granted outside of the company's 2023 Long-Term Incentive Plan. EyePoint, Inc. is listed on the Nasdaq under the symbol EYPT and focuses on developing and marketing therapies to aid patients with serious retinal ailments. This move aligns with NASDAQ Listing Rule 5635(c)(4) regulations."
datetime: "2026-07-16T11:03:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292896946.md)
  - [en](https://longbridge.com/en/news/292896946.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292896946.md)
generator: "portal-rs"
---

# EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint, Inc., a company based in Watertown, Mass., disclosed on July 16, 2026, that it has issued non-statutory stock options to new employees as part of their inducement awards. These options were granted outside of the company's 2023 Long-Term Incentive Plan. EyePoint, Inc. is listed on the Nasdaq under the symbol EYPT and focuses on developing and marketing therapies to aid patients with serious retinal ailments. This move aligns with NASDAQ Listing Rule 5635(c)(4) regulations.

### Related Stocks

- [EYPT.US](https://longbridge.com/en/quote/EYPT.US.md)

## Related News & Research

- [13:03 ETEYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals](https://longbridge.com/en/news/296520819.md)
- [These Analysts Slash Their Forecasts On EyePoint](https://longbridge.com/en/news/296252754.md)
- [EyePoint rebounds after selloff despite multiple downgrades](https://longbridge.com/en/news/296243335.md)
- [EyePoint stock craters 71% after drug trial failure. It may be an overreaction.](https://longbridge.com/en/news/296132806.md)
- [EyePoint director Karen Zaderej reports purchase of 10,600 shares worth $52,258](https://longbridge.com/en/news/296265357.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**